EP2870130A4 - COMPOSITIONS AND METHODS FOR TREATING MODERATE TO ACUTE PAIN - Google Patents

COMPOSITIONS AND METHODS FOR TREATING MODERATE TO ACUTE PAIN

Info

Publication number
EP2870130A4
EP2870130A4 EP13813543.9A EP13813543A EP2870130A4 EP 2870130 A4 EP2870130 A4 EP 2870130A4 EP 13813543 A EP13813543 A EP 13813543A EP 2870130 A4 EP2870130 A4 EP 2870130A4
Authority
EP
European Patent Office
Prior art keywords
moderate
compositions
treatment
methods
severe pain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13813543.9A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2870130A2 (en
Inventor
Mahesh Kandula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cellix Bio Pvt Ltd
Original Assignee
Cellix Bio Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Pvt Ltd filed Critical Cellix Bio Pvt Ltd
Publication of EP2870130A2 publication Critical patent/EP2870130A2/en
Publication of EP2870130A4 publication Critical patent/EP2870130A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/04Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
EP13813543.9A 2012-07-03 2013-06-23 COMPOSITIONS AND METHODS FOR TREATING MODERATE TO ACUTE PAIN Withdrawn EP2870130A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2682CH2012 2012-07-03
PCT/IB2013/055146 WO2014006529A2 (en) 2012-07-03 2013-06-23 Compositions and methods for the treatment of moderate to severe pain

Publications (2)

Publication Number Publication Date
EP2870130A2 EP2870130A2 (en) 2015-05-13
EP2870130A4 true EP2870130A4 (en) 2015-12-02

Family

ID=54188020

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13813543.9A Withdrawn EP2870130A4 (en) 2012-07-03 2013-06-23 COMPOSITIONS AND METHODS FOR TREATING MODERATE TO ACUTE PAIN

Country Status (8)

Country Link
EP (1) EP2870130A4 (zh)
JP (1) JP2015527309A (zh)
CN (1) CN104583162A (zh)
AU (1) AU2013285126A1 (zh)
CA (1) CA2873018A1 (zh)
SG (1) SG11201407328TA (zh)
WO (1) WO2014006529A2 (zh)
ZA (1) ZA201408057B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104379589A (zh) * 2012-05-07 2015-02-25 塞利克斯比奥私人有限公司 抗血小板药剂的前药
WO2016046674A1 (en) * 2014-09-28 2016-03-31 Mohan M Alapati Compositions and methods for the treatment of moderate to severe pain
CN105037241B (zh) * 2015-06-19 2018-02-23 上海上药新亚药业有限公司 1‑(2,6‑二氯苯基)‑2‑吲哚酮的合成工艺
CN111116391A (zh) * 2019-12-17 2020-05-08 浙江工业大学 一种2-[(2,6-二氯苯基)氨基]苯乙酸钠的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132318A (en) * 1966-03-30 1968-10-30 Geigy Ag J R New substituted phenylacetic esters, their production and compositions containing them
GB1582420A (en) * 1977-05-11 1981-01-07 Ciba Geigy Ag Phenylamino phenylacetic acid amide compounds and processes for their preparation
WO2009037707A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU514991B2 (en) * 1976-05-26 1981-03-12 Commonwealth Of Australia, The Pharmaceutical compositions containing antiinflammatory analgesic compounds
JPS5412340A (en) * 1977-06-27 1979-01-30 Daito Koeki Process for preparing phenylacetate derivative
NL8602767A (nl) * 1986-10-31 1988-05-16 Gantax Nv Organisch zuuranhydride, alsmede farmaceutisch preparaat op basis van een prodrug.
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH1143467A (ja) * 1997-05-14 1999-02-16 Ikeda Mohandou:Kk 脂肪酸グリセライド誘導体及びグリセライド誘導体、並びにそれらの製造方法
US6429223B1 (en) * 2000-06-23 2002-08-06 Medinox, Inc. Modified forms of pharmacologically active agents and uses therefor
CN101186583B (zh) * 2007-12-20 2011-05-11 吉林大学 2-(2-(2,6-二氯苯基氨基)苯基)醋酸甲酯及其合成方法及其应用
BRPI0901298A2 (pt) * 2009-04-06 2011-01-04 Ems Sa derivados ftalimìdicos de compostos antiinflamatórios não-esteróide e/ou moduladores de tnf-(alfa), processo de sua obtenção, composições farmacêuticas contendo os mesmos e seus usos no tratamento de doenças inflamatórias
US9525998B2 (en) * 2012-01-06 2016-12-20 Qualcomm Incorporated Wireless display with multiscreen service
EP2807784A1 (en) * 2012-01-27 2014-12-03 Interdigital Patent Holdings, Inc. Systems and/or methods for providing epdcch in a multiple carrier based and/or quasi-collated network
AU2013257706A1 (en) * 2012-05-07 2014-11-27 Cellixbio Private Limited Compositions and methods for the treatment of neurological disorders
CN104379589A (zh) * 2012-05-07 2015-02-25 塞利克斯比奥私人有限公司 抗血小板药剂的前药
WO2013167989A2 (en) * 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of neurological disorders
WO2013167986A2 (en) * 2012-05-08 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of epilepsy
AU2013257708A1 (en) * 2012-05-08 2014-12-04 Cellixbio Private Limited Compositions and methods for the treatment of diabetes
JP2015520748A (ja) * 2012-05-08 2015-07-23 セリックスビオ プライヴェート リミテッド 炭酸脱水酵素活性の抑制のための組成物及び方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132318A (en) * 1966-03-30 1968-10-30 Geigy Ag J R New substituted phenylacetic esters, their production and compositions containing them
GB1582420A (en) * 1977-05-11 1981-01-07 Ciba Geigy Ag Phenylamino phenylacetic acid amide compounds and processes for their preparation
WO2009037707A2 (en) * 2007-09-20 2009-03-26 Ramot At Tel Aviv University Ltd. N-phenyl anthranilic acid derivatives and uses thereof
US20090082450A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched diclofenac

Also Published As

Publication number Publication date
SG11201407328TA (en) 2014-12-30
EP2870130A2 (en) 2015-05-13
WO2014006529A2 (en) 2014-01-09
JP2015527309A (ja) 2015-09-17
WO2014006529A3 (en) 2014-04-24
CN104583162A (zh) 2015-04-29
CA2873018A1 (en) 2014-01-09
ZA201408057B (en) 2016-03-30
AU2013285126A1 (en) 2014-11-27

Similar Documents

Publication Publication Date Title
IL266582A (en) Compositions and methods for the treatment of hemoglobinopathies
EP2836270A4 (en) SYSTEMS AND METHODS RELATED TO THE TREATMENT OF BACK PAIN
HUE041553T2 (hu) Lizoszomális tárolási betegségek (LSD) kezelése és génterápia
EP2831001A4 (en) COMPOSITION FOR THE TREATMENT OF WATER AND METHOD FOR USE
IL221476A0 (en) Methods and compositions to treat hemorrhagic conditions of the brain
IL238177A0 (en) Methods and preparations for the treatment of cancer
EP2654745A4 (en) COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN
EP2616094A4 (en) TREATMENT OF BRAIN INJURIES THROUGH IMPORTS
PL2892556T3 (pl) Kompozycje i sposoby odnoszące się do leczenia chorób
HK1208598A1 (zh) 治療疼痛的方法及組合物
ZA201408055B (en) Compositions and methods for the treatment of local pain
HRP20181761T1 (hr) Novi pripravak alfentanila za liječenje akutne boli
ZA201408062B (en) Compositions and methods for the treatment of multiple sclerosis
EP2958591A4 (en) METHODS AND COMPOSITIONS RELATED TO THE TREATMENT OF CANCER
ZA201408057B (en) Compositions and methods for the treatment of moderate to severe pain
EP2879495A4 (en) COMPOSITIONS AND METHODS OF TREATING NEUROPSYCHOLOGICAL DEFICIENCIES
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
ZA201408065B (en) Compositions and methods for the treatment of diabetes
PL3079684T3 (pl) Kompozycje i sposoby do leczenia chorób związanych z układem renina-angiotensyna
EP2825184A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF PAIN
SG11201504779YA (en) Methods and compositions relating to treatment of cancer
EP2916831A4 (en) RADIOGRAPHIC CONTRAST MEDIUM COMPOSITIONS AND METHODS OF USE FOR TREATING INFLAMMATION AND CONDITIONS ASSOCIATED WITH INFLAMMATION.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150203

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20151102

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 29/00 20060101ALI20151027BHEP

Ipc: A61K 31/02 20060101ALI20151027BHEP

Ipc: A61P 25/04 20060101ALI20151027BHEP

Ipc: C07C 25/08 20060101AFI20151027BHEP

Ipc: A61K 31/136 20060101ALI20151027BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20160913